(Q84367711)

English

The longest ever randomised controlled trial of insulin glargine: study design and HbA(1c) findings

scientific article published on 07 August 2009

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

19662377

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19662377%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 February 2020

title

The longest ever randomised controlled trial of insulin glargine: study design and HbA(1c) findings (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

19662377

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19662377%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

C J Currie

1

1 reference

stated in

Europe PubMed Central

PubMed ID

19662377

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19662377%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 February 2020

publication date

7 August 2009

1 reference

stated in

Europe PubMed Central

PubMed ID

19662377

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19662377%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

Europe PubMed Central

PubMed ID

19662377

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19662377%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 February 2020

volume

52

1 reference

stated in

Europe PubMed Central

PubMed ID

19662377

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19662377%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 February 2020

issue

10

1 reference

stated in

Europe PubMed Central

PubMed ID

19662377

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19662377%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 February 2020

page(s)

2234-5; author reply 2236-9

1 reference

stated in

Europe PubMed Central

PubMed ID

19662377

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19662377%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 February 2020

exact match

https://scigraph.springernature.com/pub.10.1007/s00125-009-1477-6

0 references

1 reference

https://pubmed.ncbi.nlm.nih.gov/19662377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does diabetes therapy influence the risk of cancer?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19662377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

(Q84367711)

The longest ever randomised controlled trial of insulin glargine: study design and HbA(1c) findings

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)